Exact Sciences
EXAS
#1764
Rank
โ‚ฌ8.88 B
Marketcap
48,00ย โ‚ฌ
Share price
-3.29%
Change (1 day)
-13.94%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total assets

Total assets on the balance sheet as of September 2024 : โ‚ฌ6.29 Billion

According to Exact Sciences's latest financial reports the company's total assets are โ‚ฌ6.29 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exact Sciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31โ‚ฌ5.85 B0.84%
2022-12-31โ‚ฌ5.80 B-1.66%
2021-12-31โ‚ฌ5.90 B47.41%
2020-12-31โ‚ฌ4.00 B27.95%
2019-12-31โ‚ฌ3.12 B134.91%
2018-12-31โ‚ฌ1.33 B167.05%
2017-12-31โ‚ฌ0.49 B39.17%
2016-12-31โ‚ฌ0.35 B7.66%
2015-12-31โ‚ฌ0.33 B29.44%
2014-12-31โ‚ฌ0.25 B142.26%
2013-12-31โ‚ฌ0.10 B25.26%
2012-12-31โ‚ฌ84.76 M13.53%
2011-12-31โ‚ฌ74.65 M2.89%
2010-12-31โ‚ฌ72.56 M303.41%
2009-12-31โ‚ฌ17.98 M326.34%
2008-12-31โ‚ฌ4.21 M-57.79%
2007-12-31โ‚ฌ9.99 M-44.74%
2006-12-31โ‚ฌ18.08 M-43.38%
2005-12-31โ‚ฌ31.94 M-22.77%
2004-12-31โ‚ฌ41.36 M50.16%
2003-12-31โ‚ฌ27.54 M-42.51%
2002-12-31โ‚ฌ47.91 M-32.94%
2001-12-31โ‚ฌ71.44 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚ฌ1.01 B-83.92%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.18 B-81.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ20.6 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ129.69 B 1,961.10%๐Ÿ‡ซ๐Ÿ‡ท France